chitosan has been researched along with Bone Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 8 (27.59) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Ding, C; Li, J; Luo, J; Peng, X; Sun, F; Wu, M; Xia, Y; Xin, Q; Xu, X; Zhang, H; Zhao, Y; Zuo, L | 1 |
| Bai, L; He, M; Ren, Z; Xiao, W | 1 |
| Choe, W; Moqbel, SAA; Ri, J; Sim, I; Su, H; Yan, W | 1 |
| Boccaccini, AR; Ciraldo, FE; Cresswell, M; Gritsch, L; Jackson, PR; Lovell, C; Maqbool, M; Mouriño, V | 1 |
| Bose, S; Koski, C; Vu, AA | 1 |
| Borges, A; Mello, D; Sato, T; Valente, AJM; Vasconcellos, L | 1 |
| Cai, C; Chen, Y; Chen, Z; Li, H; Liu, H; Zhang, R; Zheng, B | 1 |
| Asemi, Z; Hallajzadeh, J; Maleki Dana, P; Mansournia, MA; Yousefi, B | 1 |
| Cheng, DD; Guo, H; Li, SJ; Pan, Z; Wei, XJ; Yang, QC | 1 |
| Li, S; Xiong, Y; Zhang, X | 1 |
| Chi, Y; Feng, S; Guo, C; Liu, J; Sun, K; Wu, Z; Yin, X | 2 |
| Huang, LL; Li, D; Pang, JD; Sun, K; Wang, F; Wang, LT; Wang, R; Zhang, LM | 1 |
| Guo, Y; Ke, Q; Lu, J; Peng, X; Xie, X; Yang, F | 1 |
| Guo, Z; Hamilton, AR; Jiang, N; Li, Y; McCoy, CP; Moore, J; Rafferty, C; Sarri, G; Sun, D; Zhang, L; Zhu, S; Ziminska, M | 1 |
| Chen, S; Kumta, SM; Lau, P; Lei, M; Peng, J; Qin, L; Tang, T; Wang, X | 1 |
| Dass, CR; Dunstan, DE; Elahy, M; Friedhuber, AM; Indumathy, S; Shao, P; Tan, ML; van Moorst, M; Wei, Y | 1 |
| Castro, NJ; Fu, SW; Fu, Y; Wang, M; Zhang, LG; Zhu, W | 1 |
| Blessing, AM; Frigo, DE; Gallick, GE; Gaur, S; Ivan, C; Lopez-Berestein, G; Mangala, LS; Parikh, NU; Shi, Y; Song, JH; Sood, AK; Varkaris, A; Wen, Y; Wu, SY | 1 |
| Li, M; Liu, BM; Wang, SY; Yin, BS; Zhang, WG; Zou, JY | 1 |
| Bertrand, JR; Elhamess, H; Maccario, J; Maksimenko, A; Malvy, C | 1 |
| Choong, PF; Dass, CR; Dunstan, DE; Friedhuber, AM; Tan, ML | 1 |
| Kai, H; Madhukar, KS; Qin, L; Wang, X; Yan, Y; Zhang, R | 1 |
| Anitha, A; Chennazhi, KP; Jayakumar, R; Nair, SV; Narayanan, D | 1 |
| Dass, CR; Friedhuber, AM; Tan, ML | 1 |
| Ni, M; Ratner, B; Zhang, M; Zhang, Y | 1 |
| Fernandes, MH; Hayakawa, S; Lopes, MA; Osaka, A; Santos, JD; Shirosaki, Y; Tsuru, K | 1 |
| Choong, PF; Contreras, KG; Dass, CR; Dunstan, DE | 1 |
| Chen, A; Hou, C; Zhang, Y | 1 |
1 review(s) available for chitosan and Bone Neoplasms
| Article | Year |
|---|---|
Chitosan applications in studying and managing osteosarcoma.
Topics: Biocompatible Materials; Bone Neoplasms; Chitin; Chitosan; Drug Delivery Systems; Humans; Osteosarcoma; Tissue Engineering | 2021 |
28 other study(ies) available for chitosan and Bone Neoplasms
| Article | Year |
|---|---|
Chitosan based photothermal scaffold fighting against bone tumor-related complications: Recurrence, infection, and defects.
Topics: Bone Neoplasms; Chitosan; Escherichia coli; Humans; Osteogenesis; Staphylococcus aureus; Tissue Scaffolds | 2023 |
Chitosan targets PI3K/Akt/FoxO3a axis to up-regulate FAM172A and suppress MAPK/ERK pathway to exert anti-tumor effect in osteosarcoma.
Topics: Bone Neoplasms; Cell Line, Tumor; Chitosan; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proteins; Proto-Oncogene Proteins c-akt | 2023 |
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chitosan; Humans; Oligosaccharides; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Chitosan/hydroxyapatite composite bone tissue engineering scaffolds with dual and decoupled therapeutic ion delivery: copper and strontium.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Differentiation; Chitosan; Copper; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteosarcoma; Strontium; Tissue Engineering; Tumor Cells, Cultured | 2019 |
Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Delayed-Action Preparations; Durapatite; Humans; Osteoblasts; Osteosarcoma; Tissue Scaffolds | 2020 |
Chitosan-Based Coacervate Polymers for Propolis Encapsulation: Release and Cytotoxicity Studies.
Topics: Anti-Infective Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Chitosan; Drug Delivery Systems; Humans; Hydrogels; Osteosarcoma; Polymers; Propolis; Tumor Cells, Cultured | 2020 |
A Biocompatible, Stimuli-Responsive, and Injectable Hydrogel with Triple Dynamic Bonds.
Topics: Alginates; Biocompatible Materials; Bone Neoplasms; Cell Proliferation; Chitosan; Humans; Hydrogels; Osteosarcoma; Polymers; Polysaccharides; Tissue Engineering; Tumor Cells, Cultured | 2020 |
Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53/mTOR pathway in osteosarcoma.
Topics: Animals; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chitin; Chitosan; Cisplatin; Disease Progression; Female; Humans; Hydrolysis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Oligosaccharides; Osteosarcoma; Polymers; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2021 |
Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Humans; Methotrexate; Nanoparticles; Osteosarcoma; Poloxamer | 2017 |
Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chitin; Chitosan; Cholesterol; Cytoplasm; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Nude; Oligosaccharides; Osteosarcoma; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties | 2017 |
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendrimers; Folic Acid; Gene Silencing; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Membrane Proteins; Mice, Nude; Nanoparticles; Osteosarcoma; Polylysine; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2018 |
Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Chitin; Chitosan; Cholesterol; Doxorubicin; Drug Compounding; Drug Liberation; Estrone; Glutathione; Humans; Injections, Intravenous; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Oligosaccharides; Osteosarcoma; Particle Size; Polyethylene Glycols; Receptors, Estrogen; Technology, Pharmaceutical; Time Factors; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Magnetic Mesoporous Calcium Sillicate/Chitosan Porous Scaffolds for Enhanced Bone Regeneration and Photothermal-Chemotherapy of Osteosarcoma.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Bone Regeneration; Calcium Compounds; Calcium, Dietary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chitosan; Doxorubicin; Drug Delivery Systems; Ferric Compounds; Humans; Hyperthermia, Induced; Mesenchymal Stem Cells; Mice; Mice, Nude; Osteogenesis; Osteosarcoma; Porosity; Silicates; Tissue Engineering; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2018 |
Nanoscale Hybrid Coating Enables Multifunctional Tissue Scaffold for Potential Multimodal Therapeutic Applications.
Topics: Bone Neoplasms; Chitosan; Coated Materials, Biocompatible; Drug Liberation; Durapatite; Graphite; Humans; Hydrogen-Ion Concentration; Phototherapy; Porosity; Tissue Engineering; Tissue Scaffolds | 2019 |
Segmental composite porous scaffolds with either osteogenesis or anti-bone resorption properties tested in a rabbit ulna defect model.
Topics: Animals; Biocompatible Materials; Bone Density; Bone Neoplasms; Bone Regeneration; Bone Resorption; Calcium Phosphates; Chitosan; Female; Fractures, Bone; Osteogenesis; Phosphorylation; Porosity; Rabbits; Regeneration; Tissue Engineering; Tissue Scaffolds; Tomography, X-Ray Computed; Ulna; Wound Healing | 2017 |
The potential role of free chitosan in bone trauma and bone cancer management.
Topics: Animals; Apoptosis; Bone and Bones; Bone Neoplasms; Caspase 2; Cell Line, Tumor; Chitosan; Endothelial Cells; Female; Fetus; Fracture Healing; Fractures, Bone; Humans; Mesenchymal Stem Cells; Mice, Inbred BALB C; Osteoblasts; Osteoclasts; Pregnancy; Rats; Wounds and Injuries | 2014 |
Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study.
Topics: Biomimetic Materials; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Crystallization; Durapatite; Female; Humans; Imaging, Three-Dimensional; Mesenchymal Stem Cells; Microscopy, Electron, Transmission; Models, Biological; Nanostructures; Neoplasm Invasiveness; Osteogenesis; Tissue Engineering; Tissue Scaffolds | 2015 |
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Topics: Animals; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Humans; Male; Mice, Nude; MicroRNAs; Nanoparticles; Prostatic Neoplasms; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
Effects of Incorporating Carboxymethyl Chitosan into PMMA Bone Cement Containing Methotrexate.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Neoplasms; Cell Line, Tumor; Chitosan; Compressive Strength; Femur; Guinea Pigs; Humans; Imaging, Three-Dimensional; Lab-On-A-Chip Devices; Materials Testing; Methotrexate; Microscopy, Electron, Scanning; Polymethyl Methacrylate; Tomography, Spiral Computed | 2015 |
Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles.
Topics: Animals; Biocompatible Materials; Bone Neoplasms; Cell Proliferation; Chitosan; Female; Mice; Mice, Nude; Nanospheres; NIH 3T3 Cells; Oligonucleotides, Antisense; Sarcoma, Ewing; Xenograft Model Antitumor Assays | 2009 |
A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site.
Topics: Animals; Bone Neoplasms; Chitosan; DNA; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteosarcoma | 2010 |
Fabrication of a two-level tumor bone repair biomaterial based on a rapid prototyping technique.
Topics: Absorption; Bone Neoplasms; Bone Substitutes; Calcium Phosphates; Chitosan; Computer-Aided Design; Giant Cell Tumor of Bone; Humans; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Tissue Engineering; Tissue Scaffolds | 2009 |
Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis.
Topics: Alkaline Phosphatase; Animals; Bone Neoplasms; Cell Line; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Stability; Hemolysis; Humans; L-Lactate Dehydrogenase; Mice; Nanoparticles; NIH 3T3 Cells; Osteoblasts; Osteoporosis; Parathyroid Hormone; Particle Size | 2012 |
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Disease Progression; DNA, Catalytic; Doxorubicin; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drugs, Investigational; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Osteosarcoma; Xenograft Model Antitumor Assays | 2013 |
Calcium phosphate-chitosan composite scaffolds for bone tissue engineering.
Topics: Alkaline Phosphatase; Biocompatible Materials; Biodegradation, Environmental; Biomarkers; Bone Neoplasms; Bone Substitutes; Cell Culture Techniques; Cell Differentiation; Cell Division; Chitin; Chitosan; Durapatite; Glass; Humans; Isoenzymes; Materials Testing; Microscopy, Electron, Scanning; Neoplasm Proteins; Osteoblasts; Osteocalcin; Osteosarcoma; Solubility; Tissue Engineering; Tumor Cells, Cultured | 2003 |
In vitro cytocompatibility of MG63 cells on chitosan-organosiloxane hybrid membranes.
Topics: Alkaline Phosphatase; Biocompatible Materials; Bone Neoplasms; Calcium; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line, Tumor; Chitosan; Cross-Linking Reagents; Humans; Magnetic Resonance Spectroscopy; Materials Testing; Membranes, Artificial; Microscopy, Electron, Scanning; Neoplasm Proteins; Osteoblasts; Osteosarcoma; Silanes; Spectroscopy, Fourier Transform Infrared; Wettability | 2005 |
Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Compounding; Eye Proteins; Female; Genes, Reporter; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Nerve Growth Factors; Osteosarcoma; Particle Size; Plasmids; Serpins; Transfection | 2007 |
[In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Chitin; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Osteosarcoma; Random Allocation; Tumor Cells, Cultured | 1997 |